AstraZeneca (Netherlands)
In research, AstraZeneca (Netherlands) stands highest in Medicine (#12,592 of 17,978 worldwide) and Health Sciences (#15,522 of 20,462 worldwide), over all time.
- World rank, 2022–2025
- #9,315 of 28,054 · #15,152 all time
- Rank in Netherlands
- #77 of 237
- Research works
- 220 ▲ 125% vs 2013–17
- Citations
- 4.9k 22.3 per fractional work
- Top-10% rate
- 22.3% record average 16.5%
- Open access
- 56% world 28%
What is AstraZeneca (Netherlands) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #12,592 of 17,978 | 23.4% | 125 | |
| Health SciencesDomain | #15,522 of 20,462 | 22.7% | 132 |
Each strip is that field’s whole ranked pool, with the notch where AstraZeneca (Netherlands) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.8×
- Immunology and Microbiology 8.3×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Chemistry 3.0×
- Medicine 2.7×
- Economics, Econometrics and Finance 1.1×
- Health Professions 0.8×
- Nursing 0.5×
- Neuroscience 0.5×
- Mathematics 0.4×
- Decision Sciences 0.3×
- Agricultural and Biological Sciences 0.2×
- Materials Science 0.2×
- Computer Science 0.2×
- Physics and Astronomy 0.2×
- Environmental Science 0.1×
- Engineering 0.1×
- Psychology 0.1×
- Social Sciences 0.1×
- Earth and Planetary Sciences 0.0×
- Business, Management and Accounting 0.0×
Which keywords describe research at AstraZeneca (Netherlands)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Chemotherapy, Clinical Trials, Targeted Therapy, Tumor Microenvironment, Treatment, Immunotherapy and Epidemiology.
- COPD
- Biopharmaceuticals
- Glycosylation
- Chimeric Antigen Receptor
- Tumor Regression
- ALK Inhibitors
- PD-1 and PD-L1
- Global Burden
- Breast Cancer
- Allergic Diseases
- Biomarkers
- Genomic Profiling
- Immunology
- Management
- Immunity
- Immunotherapy
- Tumor Microenvironment
- Clinical Trials
- Treatment
- Epidemiology
- Inflammation
- Chemotherapy
- Cancer
- Targeted Therapy
- Diagnosis
- Cancer Immunotherapy
- Genetics
- Monoclonal Antibodies
- Lymphoma
- Heart Failure
- Treatment Guidelines
- Asthma
- Eosinophils
- Immune Checkpoint Blockade
- Therapeutic Antibodies
- EGFR Mutations
- CAR T Cells
- TGF-ß
- Respiratory
- Immunogenicity
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation9▲ 5.0×35 topics
- Epidemiology7▲ 2.1×27 topics
- Chemotherapy5▲ 8.4×15 topics
- Treatment5▲ 4.8×11 topics
- Cancer5▲ 4.2×26 topics
- Clinical Trials5▲ 8.4×9 topics
- Targeted Therapy4▲ 23×4 topics
- Tumor Microenvironment4▲ 11×8 topics
- Diagnosis4▲ 5.2×10 topics
- Immunotherapy4▲ 6.8×11 topics
- Cancer Immunotherapy4▲ 26×3 topics
- Immunity4▲ 10.0×6 topics
- Genetics3▲ 5.3×6 topics
- Management3▲ 4.7×7 topics
- Monoclonal Antibodies3▲ 41×3 topics
- Immunology3▲ 29×2 topics
- Lymphoma3▲ 19×3 topics
- Genomic Profiling3▲ 29×2 topics
- Heart Failure3▲ 6.9×9 topics
- Biomarkers2▲ 4.2×11 topics
- Treatment Guidelines2▲ 13×3 topics
- Allergic Diseases2▲ 47×1 topic
- Asthma2▲ 29×2 topics
- Breast Cancer2▲ 12×9 topics
- Eosinophils2▲ 47×1 topic
- Global Burden2▲ 5.1×3 topics
- Immune Checkpoint Blockade2▲ 25×1 topic
- PD-1 and PD-L12▲ 25×1 topic
- Therapeutic Antibodies2▲ 39×2 topics
- ALK Inhibitors2▲ 43×1 topic
- EGFR Mutations2▲ 43×1 topic
- Tumor Regression2▲ 24×2 topics
- CAR T Cells2▲ 34×1 topic
- Chimeric Antigen Receptor2▲ 34×1 topic
- TGF-ß2▲ 17×4 topics
- Glycosylation2▲ 21×3 topics
- Respiratory2▲ 23×2 topics
- Biopharmaceuticals2▲ 40×2 topics
- Immunogenicity2▲ 48×2 topics
- COPD2▲ 30×1 topic
Which research topics does AstraZeneca (Netherlands) publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Asthma and respiratory diseases, Lung Cancer Treatments and Mutations and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 2 Asthma and respiratory diseases Physiology 2 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 4 CAR-T cell therapy research Oncology 2 works
- 5 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
- 6 Immune cells in cancer Immunology 2 works
- 7 Drug Solubulity and Delivery Systems Pharmaceutical Science 1 works
- 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 10 Cancer Genomics and Diagnostics Cancer Research 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AstraZeneca (Netherlands)'s research output changed?
Output in 2018–2022 was 125% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zoetermeer
- Ipse de Bruggen
- Lange Land Ziekenhuis
- Panteia (Netherlands)
- Dunea
- Kennisnet
- Pervatech (Netherlands)
- Dräger (Netherlands)
- Stichting OFOM
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.